The global amniotic membrane market revenue is expected to expand at a lucrative CAGR over the forecast period. Amniotic membrane can be used for treating skin-related disorders, burns, ENT surgery, dental surgery, periodontal therapy, etc., and this coupled with high prevalence of skin disorders among the global population is expected to drive growth of the global market over the forecast period.

The global amniotic membrane market is segmented into product, application, end user, and region. On the basis of product, the global market is segmented into cryopreserved amniotic membrane and lyophilization amniotic membrane. The lyophilization amniotic membrane segment is expected to grow at moderate rate over the forecast period. Lyophilization amniotic membrane reduces preservation costs, facilitates storage and transport, and may encourage use of amniotic membranes successfully in surgical procedures

On the basis of application, the global market is segmented into surgical wound, ophthalmology, and others. The ophthalmology segment is expected to grow at steady rate over the forecast period. Amniotic membrane is widely used in eye surgery as a biological bandage to heal or replace damaged eye tissue. In addition, amniotic membrane is thin, lightweight, elastic, and almost transparent, thus making it suitable for use on the surface of the eye. These are major factors favoring adoption of amniotic membranes in ophthalmology applications.

On the basis of end user, the global market is segmented into hospitals, ambulatory surgical centers, specialized clinics, and research centers and laboratory. Moderate revenue share growth of the hospitals segment in the global amniotic membrane market is attributable to availability of various reimbursement policies and robust patient pool in hospitals.

On the basis of region, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is estimated to account for highest share in terms of revenue in the global market. Increasing prevalence of surgical procedures in countries in the region is also projected to propel demand for amniotic membrane treatments, therapies, and injection etc. The Asia Pacific amniotic membrane market is expected to witness highest growth in terms of revenue over the forecast period.

Key players operating in the global market include Tissuetech, Inc., Integra LifeSciences Holdings Corporation (Derma Sciences Inc.), Alliqua BioMedical, Inc. (Celularity, Inc.), Skye Biologics, Inc., Human Regenerative Technologies, LLC, MiMedx Group, Inc., Amnio Technology, LLC, and Katena Products Inc.